Skip to main navigation Skip to search Skip to main content

Hypomethylating agents (HMAs) effect on myelodysplastic/myeloproliferative neoplasm unclassifiable (MDS/MPN-U): single institution experience

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)2737-2739
Number of pages3
JournalLeukemia and Lymphoma
Volume59
Issue number11
DOIs
StatePublished - Nov 2 2018

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this